Hinke, Daniëla Maria http://orcid.org/0000-0002-3932-8762
Anderson, Ane Marie
Katta, Kirankumar
Laursen, Marlene Fyrstenberg http://orcid.org/0000-0002-2804-0026
Tesfaye, Demo Yemane
Werninghaus, Ina Charlotta
Angeletti, Davide http://orcid.org/0000-0002-5256-1972
Grødeland, Gunnveig http://orcid.org/0000-0001-6285-3162
Bogen, Bjarne http://orcid.org/0000-0001-5387-7461
Braathen, Ranveig http://orcid.org/0000-0003-0451-5936
Article History
Received: 26 October 2022
Accepted: 9 January 2024
First Online: 12 February 2024
Competing interests
: The authors declare the following competing interest: the research funding did not have any role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript. B.B. holds shares in Nykode A.S. The TTO office of the University of Oslo and Oslo University Hospital, Inven2, has filed a patent application, WO 2019048928 National phase, “Vaccine molecules”, related to the valency-based immune-selection strategy described in the manuscript. R.B. and B.B. are inventors of this patent. The remaining authors declare no competing interests.